Literature DB >> 8363367

Antibiotic susceptibilities of Afipia felis in axenic medium and in cells.

M Maurin1, H Lepocher, D Mallet, D Raoult.   

Abstract

Afipia felis, one of the putative agents of cat scratch disease (CSD), is a facultative intracellular bacterium. Although CSD is considered not to be susceptible to antibiotic therapy, sporadic case reports indicated that aminoglycosides may be effective. We determined the in vitro antibiotic susceptibilities of three A. felis strains in axenic medium and in a cell model. In axenic medium, A. felis was susceptible to imipenem, aminoglycosides, and rifampin when using either the broth dilution technique or the agar technique. When grown in HeLa cells, A. felis was susceptible to amikacin and tobramycin but was resistant to the other compounds tested. Despite its intracellular location, A. felis can apparently be reached by aminoglycosides. Thus, the in vitro data presented here are in accord with the clinical data obtained in patients suffering CSD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363367      PMCID: PMC187984          DOI: 10.1128/AAC.37.7.1410

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease.

Authors:  R L Regnery; J G Olson; B A Perkins; W Bibb
Journal:  Lancet       Date:  1992-06-13       Impact factor: 79.321

2.  Case 22-1992--pathogenesis of cat scratch disease.

Authors:  B A Perkins; B Swaminathan; L A Jackson; D J Brenner; J D Wenger; R L Regnery; D J Wear
Journal:  N Engl J Med       Date:  1992-11-26       Impact factor: 91.245

3.  Treatment of adult systemic cat scratch disease with gentamicin sulfate.

Authors:  D E Lewis; M R Wallace
Journal:  West J Med       Date:  1991-03

Review 4.  Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous vascular disorder.

Authors:  C J Cockerell; P E LeBoit
Journal:  J Am Acad Dermatol       Date:  1990-03       Impact factor: 11.527

5.  Intracellular growth of Afipia felis, a putative etiologic agent of cat scratch disease.

Authors:  K A Birkness; V G George; E H White; D S Stephens; F D Quinn
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

6.  Cat scratch disease: a bacterial infection.

Authors:  D J Wear; A M Margileth; T L Hadfield; G W Fischer; C J Schlagel; F M King
Journal:  Science       Date:  1983-09-30       Impact factor: 47.728

7.  Antimicrobial susceptibility of intracellular Legionella pneumophila.

Authors:  M A Bacheson; H M Friedman; C E Benson
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

8.  Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations.

Authors:  D Lucey; M J Dolan; C W Moss; M Garcia; D G Hollis; S Wegner; G Morgan; R Almeida; D Leong; K S Greisen
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

9.  An atypical subcutaneous infection associated with acquired immune deficiency syndrome.

Authors:  M H Stoler; T A Bonfiglio; R T Steigbigel; M Pereira
Journal:  Am J Clin Pathol       Date:  1983-11       Impact factor: 2.493

10.  Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies.

Authors:  D J Brenner; D G Hollis; C W Moss; C K English; G S Hall; J Vincent; J Radosevic; K A Birkness; W F Bibb; F D Quinn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

View more
  5 in total

Review 1.  Current knowledge of Bartonella species.

Authors:  M Maurin; R Birtles; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

Review 2.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

3.  Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats.

Authors:  D L Kordick; M G Papich; E B Breitschwerdt
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

4.  Expression of tfx and sensitivity to the rhizobial peptide antibiotic trifolitoxin in a taxonomically distinct group of alpha-proteobacteria including the animal pathogen Brucella abortus.

Authors:  E W Triplett; B T Breil; G A Splitter
Journal:  Appl Environ Microbiol       Date:  1994-11       Impact factor: 4.792

5.  Antibiotic and Disinfectant Resistance in Tap Water Strains - Insight into the Resistance of Environmental Bacteria.

Authors:  Agata Siedlecka; Mirela J Wolf-Baca; Katarzyna Piekarska
Journal:  Pol J Microbiol       Date:  2021-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.